HSE approves 'groundbreaking' cystic fibrosis drug for children aged 6-11

HSE approves 'groundbreaking' cystic fibrosis drug for children aged 6-11

A demonstration at Leinster House last September calling for the availability of Kaftrio for children with cystic fibrosis. File picture: Shane O'Neill

The families of 35 children with cystic fibrosis are celebrating after the drug Kaftrio was approved by the HSE for use by children aged between 6-11.

The drug had previously been excluded from the children within this age bracket. It has now been extended for use following lengthy engagements with the drug manufacturer Vertex.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited